Drug Type Biological products |
Synonyms HT006.2.2 |
Target |
Action activators, agonists |
Mechanism TrkA activators(Nerve growth factor receptor Trk-A activators), p75NTR agonists(Low affinity neurotrophin receptor p75NTR agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neurotrophic keratitis | Phase 1 | China | 26 Feb 2024 |





